What We're Reading: Page 29
Industry reads hand-picked by our editors
Jun 04, 2025
-
The Economist
The Alzheimer’s drug pipeline is healthier than you might think
-
The New York Times
From No Hope to a Potential Cure for a Deadly Blood Cancer
-
BioCentury
Lawsuit challenges layoffs at FDA, other HHS agencies
Jun 03, 2025
-
The Wall Street Journal
How Moderna Went From Pandemic Hero to Vaccine Victim
-
The Financial Times
Merck held talks to buy Swiss biotech MoonLake for more than $3bn
-
Bloomberg
AI Drug Startup Touts Promising Advance in Treating Lung Disease
Jun 02, 2025
May 30, 2025
-
The Wall Street Journal
U.S. VCs Race to Tap China’s Biotech Innovation
-
Bloomberg
Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives
-
NOTUS
The MAHA Report Cites Studies That Don’t Exist
May 29, 2025
-
Axios
China’s biotech boom leaves U.S. playing catch-up
-
The Washington Post
CDC blindsided as RFK Jr. changes vaccine recommendations
-
The Atlantic
The Perilous Spread of the Wellness Craze
May 28, 2025
-
Bloomberg
RFK Jr.’s Vow to End TV Drug Ads Threatens Broadcast Networks
-
MarketWatch
Vivek Ramaswamy’s firm wants to buy biotech companies to bet on bitcoin
-
Politico
RFK Jr. threatens to bar government scientists from publishing in leading medical journals
-
PharmaVoice
What’s next for Trump’s ‘most favored nation’ policy?
Previous
